PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. | 28011624 | Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, Bauer DC, Dorgan JF, Shu XO, Zheng W, Brinton LA, Gail MH, Ziegler RG, Xu X, Hoover RN, Gierach GL | Cancer Res. | 2017 | PLCO |
| Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial. | 28669054 | Marous M, Huang WY, Rabkin CS, Hayes RB, Alderete JF, Rosner B, Grubb RL, Winter AC, Sutcliffe S | Cancer Causes Control | 2017 | PLCO |
| A prospective study of mitochondrial DNA copy number and the risk of prostate cancer. | 28357528 | Moore A, Lan Q, Hofmann JN, Liu CS, Cheng WL, Lin TT, Berndt SI | Cancer causes & control : CCC | 2017 | PLCO |
| Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. | 28701476 | Kim J, Bamlet WR, Oberg AL, Chaffee KG, Donahue G, Cao XJ, Chari S, Garcia BA, Petersen GM, Zaret KS | Sci Transl Med | 2017 | PLCO |
| Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative. | 28676217 | Tao MH, Dai Q, Chen S, Freudenheim JL, Rohan T, Wakelee H, Datta M, Wactawski-Wende J | Lung Cancer | 2017 | PLCO |
| Interactions between calcium intake and polymorphisms in genes essential for calcium reabsorption and risk of colorectal neoplasia in a two-phase study. | 28544176 | Zhao J, Zhu X, Shrubsole MJ, Ness RM, Hibler EA, Cai Q, Long J, Chen Z, Jiang M, Kabagambe EK, Zhang B, Hou L, Smalley WE, Edwards TL, Giovannucci EL, Zheng W, Dai Q | Mol Carcinog | 2017 | PLCO |
| Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps. | 28501704 | Sun P, Zhu X, Shrubsole MJ, Ness RM, Hibler EA, Cai Q, Long J, Chen Z, Li G, Hou L, Smalley WE, Edwards TL, Giovannucci E, Zheng W, Dai Q | J Nutr Biochem | 2017 | PLCO |
| Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival. | 28681154 | Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R | Ann Surg Oncol | 2017 | PLCO |
| Leukocyte telomere length and renal cell carcinoma survival in two studies. | 28742796 | Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, Purdue MP | Br J Cancer | 2017 | PLCO |
| Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. | 28699174 | Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Ellipse Consortium T, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Doherty JA, Gruber SB, Harrison TA, Hayes RB, Hoffmeister M, Houlston RS, Hung RJ, Je… | Int J Cancer | 2017 | PLCO |
| Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 25601300 | Breyer BN, Huang WY, Rabkin CS, Alderete JF, Pakpahan R, Beason TS, Kenfield SA, Mabie J, Ragard L, Wolin KY, Grubb RL, Andriole GL, Sutcliffe S | BJU Int. | 2016 | PLCO |
| Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial. | 27836710 | Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS | J. Urol. | 2016 | PLCO |
| Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel. | 27810449 | Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H | J. Urol. | 2016 | PLCO |
| Reevaluating PSA Testing Rates in the PLCO Trial. | 27144870 | Shoag JE, Mittal S, Hu JC | N. Engl. J. Med. | 2016 | PLCO |
| Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 27149646 | Bradley MC, Black A, Freedman AN, Barron TI | Cancer | 2016 | PLCO |
| Lethal Prostate Cancer in the PLCO Cancer Screening Trial. | 27166670 | Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE | Eur. Urol. | 2016 | PLCO |
| Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort. | 27687075 | Pinsky PF, Yu K, Black A, Huang WY, Prorok PC | Cancer Epidemiol | 2016 | PLCO |
| The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. | 27635065 | Zhu CS, Huang WY, Pinsky PF, Berg CD, Sherman M, Yu KJ, Carrick DM, Black A, Hoover R, Lenz P, Williams C, Hawkins L, Chaloux M, Yurgalevitch S, Mathew S, Miller A, Olivo V, Khan A, Pretzel SM, Multerer D, Beckmann P, Broski KG, Freedman ND | Cancer Epidemiol. Biomarkers Prev. | 2016 | PLCO |
| Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. | 27615399 | Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC | Gynecol. Oncol. | 2016 | PLCO |
| Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment. | 27009534 | Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS | Int. J. Cancer | 2016 | PLCO |